bosentan anhydrous has been researched along with Cancer of Colon in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bovey, R; Juillerat-Jeanneret, L; Peduto Eberl, L | 1 |
Eberl, LP; Jeannin, JF; Juillerat-Jeanneret, L; Saintgiorgio, V; Valdenaire, O | 1 |
Eberl, LP; Egidy, G; Juillerat-Jeanneret, L; Pinet, F | 1 |
Bosman, FT; Egidy, G; Jeannin, JF; Juillerat-Jeanneret, L; Korth, P; Pinet, F | 1 |
4 other study(ies) available for bosentan anhydrous and Cancer of Colon
Article | Year |
---|---|
Endothelin-receptor antagonists are proapoptotic and antiproliferative in human colon cancer cells.
Topics: Apoptosis; Base Sequence; Bosentan; Caspase 8; Caspase 9; Caspases; Cell Division; Colonic Neoplasms; DNA Primers; Endothelin Receptor Antagonists; Endothelin-1; Flow Cytometry; Humans; Immunohistochemistry; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides | 2003 |
Endothelin receptor blockade potentiates FasL-induced apoptosis in rat colon carcinoma cells.
Topics: Adenocarcinoma; Animals; Apoptosis; Aspartic Acid Endopeptidases; Bosentan; Caspase Inhibitors; Colonic Neoplasms; Drug Synergism; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-Converting Enzymes; Endothelins; Enzyme Inhibitors; Fas Ligand Protein; fas Receptor; Humans; Membrane Glycoproteins; Metalloendopeptidases; Protein Precursors; Rats; Receptors, Endothelin; RNA, Messenger; Sulfonamides; Tumor Cells, Cultured | 2000 |
Endothelin receptor blockade potentiates FasL-induced apoptosis in colon carcinoma cells via the protein kinase C-pathway.
Topics: Animals; Apoptosis; Bosentan; Colonic Neoplasms; Endothelin Receptor Antagonists; Fas Ligand Protein; Membrane Glycoproteins; Protein Kinase C; Rats; Receptor, Endothelin A; Receptor, Endothelin B; Sulfonamides; Tumor Cells, Cultured | 2000 |
Modulation of human colon tumor-stromal interactions by the endothelin system.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Animals; Aspartic Acid Endopeptidases; Bosentan; Colon; Colonic Neoplasms; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-Converting Enzymes; Endothelins; Female; Humans; Male; Metalloendopeptidases; Middle Aged; Protein Precursors; Rats; Rats, Inbred Strains; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Reference Values; RNA, Messenger; Sulfonamides; Tissue Distribution | 2000 |